DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Reck M, Kaiser R, Mellemgaard A et al.
Docetaxel plus nintedanib vs. docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Lancet Oncol 2014;
15: 143-155
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.